{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:32:43Z","timestamp":1779323563998,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Preventive Medicine"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.ypmed.2020.106064","type":"journal-article","created":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T19:45:55Z","timestamp":1585079155000},"page":"106064","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Lower rates of neural tube defects in Israel following folic acid supplementation policy"],"prefix":"10.1016","volume":"139","author":[{"given":"Annie","family":"Reiss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matan J.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ehud","family":"Kaliner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efrat","family":"Gabai Kapara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amihood","family":"Singer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itamar","family":"Grotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronni","family":"Gamzu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ypmed.2020.106064_bb0005","series-title":"The Bedouin Population in Israel \u2013 Population Register Compared With Population Estimation as Basis of Demographic Indexes","author":"Abuhazira","year":"2010"},{"issue":"1","key":"10.1016\/j.ypmed.2020.106064_bb0010","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/bdra.23100","article-title":"National Birth Defects Prevention Study. Proportion of neural tube defects attributable to known risk factors","volume":"97","author":"Agopian","year":"2013","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"4","key":"10.1016\/j.ypmed.2020.106064_bb0015","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.ypmed.2004.02.042","article-title":"Increased awareness, knowledge and utilization of preconceptional folic acid in Israel following a national campaign","volume":"39","author":"Amitai","year":"2004","journal-title":"Prev. Med."},{"issue":"2","key":"10.1016\/j.ypmed.2020.106064_bb0020","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ypmed.2007.09.005","article-title":"Preconceptional folic acid utilization in Israel: five years after the guidelines","volume":"46","author":"Amitai","year":"2008","journal-title":"Prev. Med."},{"issue":"7","key":"10.1016\/j.ypmed.2020.106064_bb0025","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/bdra.23529","article-title":"A 2015 global update on folic acid-preventable spina bifida and anencephaly","volume":"106","author":"Arth","year":"2016","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"1","key":"10.1016\/j.ypmed.2020.106064_bb0030","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.2105\/AJPH.2015.302902","article-title":"Global birth prevalence of spina bifida by folic acid fortification status: a systematic review and meta-analysis","volume":"106","author":"Atta","year":"2016","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.ypmed.2020.106064_bb0035","series-title":"Inequality in Health and Management Thereof","author":"Averbuch","year":"2010"},{"issue":"2","key":"10.1016\/j.ypmed.2020.106064_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089354","article-title":"Prevention of neural tube defects: a cross-sectional study of the uptake of folic acid supplementation in nearly half a million women","volume":"9","author":"Bestwick","year":"2014","journal-title":"PLoS One"},{"issue":"20","key":"10.1016\/j.ypmed.2020.106064_bb0045","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJM199911113412006","article-title":"Neural-tube defects","volume":"341","author":"Botto","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"7491","key":"10.1016\/j.ypmed.2020.106064_bb0050","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/bmj.38336.664352.82","article-title":"International retrospective cohort study of neural tube defects in relation to folic acid recommendations: are the recommendations working?","volume":"330","author":"Botto","year":"2005","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.ypmed.2020.106064_bb0055","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/ejcn.2015.131","article-title":"A review of European guidelines on periconceptional folic acid supplementation","volume":"70","author":"Cawley","year":"2016","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.ypmed.2020.106064_bb0060","unstructured":"Centers for Disease Control and Prevention. Knowledge and use of folic acid by women of childbearing age \u2013 United States, 1995 and 1998. MMWR Morb. Mortal. Wkly Rep. 1999;48(16);325\u20137. Available from: https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/00056982.htm."},{"issue":"RR13","key":"10.1016\/j.ypmed.2020.106064_bb0065","first-page":"9","article-title":"Spina bifida and anencephaly prevalence \u2013 United States, 1991-2001","volume":"51","author":"Centers for Disease Control and Prevention","year":"2002","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.ypmed.2020.106064_bb0070","author":"Centers for Disease Control and Prevention"},{"issue":"2","key":"10.1016\/j.ypmed.2020.106064_bb0075","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJMoa067103","article-title":"Reduction in neural-tube defects after folic acid fortification in Canada","volume":"357","author":"De Wals","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ypmed.2020.106064_bb0080","article-title":"Effects and safety of periconceptional oral folate supplementation for preventing birth defects","volume":"12","author":"De-Regil","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"issue":"3","key":"10.1016\/j.ypmed.2020.106064_bb0085","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ntt.2004.12.007","article-title":"Human neural tube defects: developmental biology, epidemiology, and genetics","volume":"27","author":"Detrait","year":"2005","journal-title":"Neurotoxicol. Teratol."},{"issue":"2","key":"10.1016\/j.ypmed.2020.106064_bb0090","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0033-3506(02)00509-7","article-title":"Association of low maternal education with neural tube defects in Colorado, 1989\u20131998","volume":"116","author":"Farley","year":"2002","journal-title":"Public Health"},{"key":"10.1016\/j.ypmed.2020.106064_bb0095","author":"Food Fortification Initiative (FFI)"},{"key":"10.1016\/j.ypmed.2020.106064_bb0100","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1046\/j.1528-1157.44.s3.2.x","article-title":"Epidemiology of neural tube defects","volume":"44","author":"Frey","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.ypmed.2020.106064_bb0105","series-title":"Social Survey 2010 (Annual Modules on Health and Way of Life), No. 1477, Table 20","article-title":"Women over 35, by targeted testing and selected traits, 2010","author":"Israeli Central Bureau of Statistics","year":"2012"},{"key":"10.1016\/j.ypmed.2020.106064_bb0110","series-title":"Statistical Abstract of Israel 2013, No. 64, Subject 2, Table 2.2","article-title":"Population, by religion","author":"Israeli Central Bureau of Statistics","year":"2013"},{"key":"10.1016\/j.ypmed.2020.106064_bb0115","series-title":"Statistical Abstract of Israel 2014, No. 65, Subject 3, Table 3.1","article-title":"Marriages, divorces, live births, deaths, natural increase, infant deaths and stillbirths, by religion","author":"Israeli Central Bureau of Statistics","year":"2014"},{"key":"10.1016\/j.ypmed.2020.106064_bb0120","series-title":"Statistical Abstract of Israel 2016, No. 67, Subject 8, Table 8.72","article-title":"Population aged 15 and over, by population group, years of schooling, age and sex","author":"Israeli Central Bureau of Statistics","year":"2016"},{"key":"10.1016\/j.ypmed.2020.106064_bb0125","series-title":"Guidelines for Folic Acid Administration: Pregnant Women and Women in their Childbearing Years","author":"Israeli Ministry of Health practice guidelines","year":"2000"},{"key":"10.1016\/j.ypmed.2020.106064_bb0130","series-title":"Open Neural Tube Defects in Israel, 1999\u20132004","author":"Israeli Ministry of Health Report","year":"2005"},{"key":"10.1016\/j.ypmed.2020.106064_bb0135","series-title":"Mortality of Infants and Children under 5, 2005","author":"Israeli Ministry of Health Report","year":"2006"},{"key":"10.1016\/j.ypmed.2020.106064_bb0140","series-title":"Pregnancy Terminations by Law, 1990\u20132014","author":"Israeli Ministry of Health Report","year":"2015"},{"key":"10.1016\/j.ypmed.2020.106064_bb0145","doi-asserted-by":"crossref","first-page":"h5949","DOI":"10.1136\/bmj.h5949","article-title":"Long term trends in prevalence of neural tube defects in Europe: population based study","volume":"351","author":"Khoshnood","year":"2015","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.ypmed.2020.106064_bb0150","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3390\/nu9020123","article-title":"Maternal folic acid supplementation during pregnancy and childhood allergic disease outcomes: a question of timing?","volume":"9","author":"McStay","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.ypmed.2020.106064_bb0155","doi-asserted-by":"crossref","first-page":"k724","DOI":"10.1136\/bmj.k724","article-title":"Do the benefits of folic acid fortification outweigh the risk of masking vitamin B12 deficiency?","volume":"360","author":"Mills","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.ypmed.2020.106064_bb0160","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1542\/peds.47.3.577","article-title":"Anencephaly and spina bifida in Israel","volume":"47","author":"Naggan","year":"1971","journal-title":"Pediatrics"},{"key":"10.1016\/j.ypmed.2020.106064_bb0165","series-title":"The Bedouin Population in the Negev: Social, Demographic and Economic Factors","author":"Rudnitzky","year":"2012"},{"issue":"1","key":"10.1016\/j.ypmed.2020.106064_bb0170","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/ajmg.c.30049","article-title":"Embryology of neural tube development","volume":"135C","author":"Sadler","year":"2005","journal-title":"Am. J. Med. Genet. C: Semin. Med. Genet."},{"key":"10.1016\/j.ypmed.2020.106064_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ypmed.2018.05.023","article-title":"Folic acid supplementation during the preconception period: a systematic review and meta-analysis","volume":"114","author":"Toivonen","year":"2018","journal-title":"Prev. Med."},{"issue":"4","key":"10.1016\/j.ypmed.2020.106064_bb0180","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ypmed.2007.08.012","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"45","author":"von Elm","year":"2007","journal-title":"Prev. Med."},{"issue":"2","key":"10.1016\/j.ypmed.2020.106064_bb0185","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1056\/NEJMp038186","article-title":"Folic acid and the prevention of neural-tube defects","volume":"350","author":"Wald","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ypmed.2020.106064_bb0190","first-page":"1","article-title":"Centers for Disease Control and Prevention. Updated estimates of neural tube defects prevented by mandatory folic acid fortification \u2013 United States, 1995-2011","volume":"64","author":"Williams","year":"2015","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"issue":"6","key":"10.1016\/j.ypmed.2020.106064_bb0195","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S1701-2163(15)30230-9","article-title":"Pre-conception folic acid and multivitamin supplementation for the primary and secondary prevention of neural tube defects and other folic acid-sensitive congenital anomalies","volume":"37","author":"Wilson","year":"2015","journal-title":"J. Obstet. Gynaecol. Can."},{"issue":"11","key":"10.1016\/j.ypmed.2020.106064_bb0200","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1007\/s00431-011-1492-8","article-title":"Economic burden of neural tube defects and impact of prevention with folic acid: a literature review","volume":"170","author":"Yi","year":"2011","journal-title":"Eur. J. Pediatr."},{"issue":"9","key":"10.1016\/j.ypmed.2020.106064_bb0205","first-page":"601","article-title":"Surveillance of neural tube defects in Israel: the effect of the recommendation for periconceptional folic acid","volume":"8","author":"Zlotogora","year":"2006","journal-title":"Isr. Med. Assoc. J."}],"container-title":["Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743520300888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743520300888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T10:12:59Z","timestamp":1758795179000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091743520300888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":41,"alternative-id":["S0091743520300888"],"URL":"https:\/\/doi.org\/10.1016\/j.ypmed.2020.106064","relation":{},"ISSN":["0091-7435"],"issn-type":[{"value":"0091-7435","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lower rates of neural tube defects in Israel following folic acid supplementation policy","name":"articletitle","label":"Article Title"},{"value":"Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ypmed.2020.106064","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106064"}}